Deep learning-based tool for automated segmentation of sclerosis lesions in 3D MRI brain scans
NeuroSense is an AI-powered clinical decision support web application for early risk assessment of Alzheimer’s Disease, Parkinson’s Disease, and Dementia using multimodal clinical data, biomarkers, and machine learning models.
End-to-end TWAS pipeline for Alzheimer's disease integrating Kunkle et al. (2019) GWAS summary statistics with GTEx v8 MASHR brain eQTL models to identify causal genes via cross-tissue omnibus regression and functional pathway over-representation analysis.
Evox Therapeutics is an Oxford, United Kingdom based biotechnology company developing genetic medicines that expand the reach of gene therapy into the brain to transform the treatment landscape for severe neurodegenerative diseases.
Using Mendelian Randomization to decipher the prodrome of Amyotrophic Lateral Sclerosis and Parkinson's Disease
Axcelius I/II is a biopharmaceutical company-creation vehicle backed by Canaan Partners, formed to found and incubate drug-development companies pursuing treatments for cancer, rare diseases, and neurodegenerative disorders.
VectorY Therapeutics is a clinical-stage biotechnology company developing novel genetic medicines for neurodegenerative diseases using its proprietary Vectorized Antibody Platform, which combines AAV-based gene delivery with antibody engineering to express therapeutic antibodies directly in the central nervous system.
Avicenna Biosciences, Inc. is a Durham, North Carolina drug development company using machine learning-enhanced medicinal chemistry to accelerate the lead-to-candidate optimization process for small molecule drug development.
Add a description, image, and links to the neurodegenerative-disease topic page so that developers can more easily learn about it.
To associate your repository with the neurodegenerative-disease topic, visit your repo's landing page and select "manage topics."